Open access
130
Views
10
CrossRef citations to date
0
Altmetric
Review
Cost-effectiveness of bortezomib for multiple myeloma: a systematic review
Wendong Chen1 Normin Health, Toronto, ON, CanadaCorrespondence[email protected]
, Yicheng Yang2 Xian Janssen, Beijing, People’s Republic of China
, Yi Chen3 Normin Health Changsha Representative Office, Changsha, People’s Republic of China
, Fen Du3 Normin Health Changsha Representative Office, Changsha, People’s Republic of China
& Huan Zhan3 Normin Health Changsha Representative Office, Changsha, People’s Republic of China
Pages 137-151
|
Published online: 03 May 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.